logo
GCC Investment Funds to Invest $100 Billion in Health-related Companies in 2025

GCC Investment Funds to Invest $100 Billion in Health-related Companies in 2025

Daily Tribune27-10-2024

A report from Bloomberg indicates a growing interest among Gulf investment funds, including those from Bahrain, in financing global healthcare initiatives. This trend comes as traditional donors from European countries face challenges in sustaining their support for the sector.
According to the report, at least five Gulf funds are planning to invest nearly $100 billion in health-related companies and initiatives by the end of next year. These investments will support vital efforts, such as childhood vaccination programmes and research into treatments for diseases that affect millions annually.
The report highlights the difficulties traditional donors, such as Germany, the UK, and France, are encountering due to economic and climate crises, which have led to reduced spending on health initiatives.
For instance, the Global Alliance for Vaccines and Immunisation (GAVI), which helps provide vaccines for diseases like cholera and measles in poorer nations, has raised only about $9 billion of its required funding, representing just one-third of its needs.
Gulf countries, including Bahrain, have pledged $267 million to GAVI initiatives, reflecting their increasing role in financing international humanitarian and health projects. While still considered small donors compared to Western nations, the GCC states are becoming crucial players in filling funding gaps left by decreasing Western support, according to the report.
Bloomberg quoted Sania Nishtar, CEO of GAVI, who stated that "the financial constraints faced by traditional donors pose significant challenges." She noted that the Group of Seven (G7) nations may have conflicting priorities regarding which health sectors should receive funding. Nishtar emphasised that GAVI is currently seeking to expand its base of supporters to include Gulf nations such as Bahrain, Saudi Arabia, the UAE, Kuwait and Qatar.
As these GCC investment funds ramp up their commitments to global health initiatives, their contributions are expected to play an essential role in addressing public health challenges worldwide.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Health Ministry launches regional workshop to advance measles elimination in Gulf region
Health Ministry launches regional workshop to advance measles elimination in Gulf region

Biz Bahrain

time7 days ago

  • Biz Bahrain

Health Ministry launches regional workshop to advance measles elimination in Gulf region

The Ministry of Health, in collaboration with the Gulf Centre for Disease Prevention and Control, launched a regional workshop focused on advancing measles elimination in the Gulf region. The event gathered health officials and stakeholders from the region to coordinate strategies and share expertise. Dr. Samya Ali Baharom, Assistant Undersecretary of Public Health at the Ministry of Health, emphasised the importance of continued regional cooperation in reducing measles cases and boosting immunisation programmess. She noted the Kingdom of Bahrain's progress in disease prevention, citing the World Health Organisation's recent recognition of the Kingdom's success in eliminating endemic measles and rubella. The workshop aims to assess the current situation, develop a unified strategy, and enhance preparedness and response. Dr. Baharom praised the shared commitment and capabilities of GCC countries in achieving the goal of measles eradication. BNA(R)

Half of Elderly Patients Prescribed Risky Medications, Study Finds
Half of Elderly Patients Prescribed Risky Medications, Study Finds

Daily Tribune

time29-05-2025

  • Daily Tribune

Half of Elderly Patients Prescribed Risky Medications, Study Finds

TDT | Manama Professor Tom Fahey, a leading expert in general practice and epidemiology, presented critical findings on the safety and appropriateness of medication use in elderly populations during the Bahrain International Conference on Family Medicine and Primary Healthcare, held at the Gulf Hotel Bahrain. Drawing from extensive Irish research, Prof. Fahey outlined trends in potentially inappropriate prescribing and adverse drug reactions, with a particular focus on patients aged 70 and above. His presentation was based on data from a large cohort study involving over 50,000 patients in the Dublin area, highlighting how hospital admission, both elective and emergency, were significantly associated with the likelihood of receiving high-risk medications. Prof. Fahey emphasized the risks of polypharmacy, the simultaneous use of multiple medications—particularly among elderly patients, linking it to increased emergency visits, hospitalizations, and functional decline. In a six-year observational study across 15 general practices in Dublin, a significant number of elderly patients experienced ADRs, with over 10% requiring emergency hospitalization. The most commonly implicated drugs were NSAIDs and certain psychoactive medications. The research also investigated the rise in the use of strong opioids, such as morphine and fentanyl, which increased from 20% to 43% over a 15-year period. Prof. Fahey warned that these drugs carry well-documented risks, particularly in older populations, mirroring concerns across other European and American healthcare systems. Another area of concern was the prescribing of medications affected by alcohol consumption. Interventions aimed at reducing alcohol-medication interactions showed modest success, though the impact on long-term health outcomes remained limited. Prof. Fahey concluded by stressing the urgent need for policy interventions, better prescribing practices, and clinical guidelines to mitigate medication-related harm in aging populations. He called for family physicians and primary healthcare providers to play a leading role in addressing inappropriate medication use and improving patient safety. - Hospitalization was a major factor associated with increased exposure to risky medications, independent of other health conditions.

Jordan leads Mena medical tourism with 224,000 visitors in 2024
Jordan leads Mena medical tourism with 224,000 visitors in 2024

Trade Arabia

time20-05-2025

  • Trade Arabia

Jordan leads Mena medical tourism with 224,000 visitors in 2024

The Jordan Tourism Board (JTB) has reported a significant increase in international medical and wellness tourism visits to the Middle East and North Africa region. In 2024, the medical tourism sector saw 224,740 visitors, with 51,448 in Q1 2025. The country's comprehensive healthcare ecosystem, including 69 private sector hospitals with 5,500 beds, has made it a preferred destination for patients seeking advanced medical treatments, particularly from GCC nations and neighboring countries. Iraq leads the international demand at 257,396 visitations, followed by Saudi Arabia at 216,256. Kuwait received over 31,920 visitors, followed by Qatar at 15,524, Bahrain at 13,856, Oman at 8,828, and the UAE at 6,584. GCC visitors value Jordan's cultural resonance, shared language, and understanding of their healthcare preferences. Jordan's geographic features provide natural therapeutic sites that complement its advanced medical facilities. The Dead Sea, 400 meters below sea level, offers exceptional therapeutic benefits through mineral-rich waters containing 33% salt content and high levels of magnesium, sodium, and bromine. The country's atmospheric conditions, including year-round UVB radiation, increased oxygen content, and minimal pollution, contribute to an optimal environment for health treatments. Wellness offerings range from Dead Sea spa treatments to the therapeutic waters of Ma'in Hot Springs, offering traditional Arabian Hammam treatments alongside modern rehabilitation therapies. Jordan's medical tourism infrastructure is supported by state-of-the-art facilities and advanced medical technology, with significant investments in modern equipment and specialised units ensuring international standards of patient care and better outcomes. "Jordan's medical tourism sector has demonstrated remarkable growth, led by theworld-class healthcare services the country offers, the natural therapeutic sites with first class resorts, and our famed hospitality," said Dr Abdelrazzak Arabiyat, Managing Director of the Jordan Tourism Board. "Our healthcare facilities maintain international standards while providing cost-effective treatments, making Jordan an attractive destination for patients seeking high quality medical care." "The diversity of medical specialties available in Jordan, combined with the expertise of our healthcare professionals, who are trusted across the GCC, has created a strong medical tourism ecosystem," added Dr Arabiyat. 'The visitors are further energised by the natural therapeutic destinations that add to the well-being of all visitors.' -TradeArabia News Service

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store